Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
NAD+ boosters enhance SIRT1 activity which can upregulate T4-to-T3 conversion and might lead to mild reductions in TSH, slight increases in free T3, and stable or modestly lower free T4 levels with limited impact on reverse T3.
Human studies are still emerging and individual responses can vary. See below for important details on dosing, lab monitoring, safety considerations, and when to seek professional guidance that could influence your next steps.
Nicotinamide adenine dinucleotide (NAD+) is a vital molecule that helps power cellular metabolism, DNA repair, and signaling pathways. In recent years, NAD+ boosters—supplements designed to raise NAD+ levels—have gained popularity for their potential to support energy, cognition, and healthy aging. But how do these supplements interact with your thyroid function and lab results? In this article, we'll explore the connection between NAD+ boosters and thyroid health, review current evidence, and provide practical guidance.
Your thyroid gland produces two main hormones:
A third key marker is Thyroid-Stimulating Hormone (TSH), produced by your pituitary gland to regulate T4/T3 production. Standard thyroid panels measure TSH, free T4, and free T3.
NAD+ is a cofactor for sirtuins (SIRT1–7), a family of enzymes involved in metabolic regulation. One of these, SIRT1, influences the activity of Type 2 deiodinase (DIO2), the enzyme that converts T4 into active T3 in tissues such as the brain, skeletal muscle, and brown fat.
Animal studies suggest that boosting NAD+ can enhance SIRT1-driven deiodinase activity, leading to better thyroid hormone activation at the tissue level. However, direct human data are limited.
TSH Levels
– Enhanced peripheral T3 production might reduce TSH via negative feedback.
– In practice, mild reductions in TSH have been observed anecdotally, but large human trials are lacking.
Free T4 and Free T3 Levels
– A modest rise in free T3 (active hormone) could occur if deiodinase activity increases.
– Free T4 may remain stable or decrease slightly as more T4 is converted into T3.
Reverse T3 (rT3)
– No clear data suggest NAD+ boosters affect rT3, an inactive form.
– Monitoring rT3 may help differentiate whether changes in T3 are due to boosted conversion or other factors.
Although animal and in vitro research points to a mechanistic link between NAD+ and deiodinase enzymes, human studies are still emerging:
Key limitations:
If you're taking—or considering—NAD+ boosters and have known thyroid issues or routine thyroid monitoring, keep the following in mind:
Most NAD+ precursors are well tolerated, but individual responses vary. Common options include:
Possible side effects:
There is no strong evidence that standard-dose NAD+ boosters directly harm thyroid function. However, because they can influence metabolic pathways, it's wise to monitor thyroid labs if you have pre-existing thyroid disease.
While NAD+ boosters may support healthy thyroid hormone conversion, they are not a substitute for medical evaluation or treatment. If you experience any of the following, seek medical attention promptly:
If you're unsure whether your symptoms warrant immediate attention, try using a free Medically Approved LLM Symptom Checker Chat Bot to get AI-powered, personalized guidance based on your specific concerns.
Disclaimer: This information is meant to complement—not replace—professional medical advice. If you suspect a serious thyroid condition or have life-threatening symptoms, please speak to a doctor as soon as possible.
(References)
* Li H, Wang J, Shi G, Xu Y, Zhang M. The Role of NAD+ and Sirtuins in Thyroid Disorders. Exp Clin Endocrinol Diabetes. 2023 Feb;131(2):77-83. doi: 10.1055/a-1910-4357. Epub 2022 Oct 26. PMID: 36283737. Available from: pubmed.ncbi.nlm.nih.gov/36283737/
* Hekmatnejad M, Gharaei R, Amini M, Asadi A, Ghasemi A. NAD+ Precursors in Thyroid Health and Disease. Horm Metab Res. 2024 Mar;56(3):141-147. doi: 10.1055/a-2187-5735. Epub 2024 Feb 5. PMID: 38318721. Available from: pubmed.ncbi.nlm.nih.gov/38318721/
* Cichon-Lach A, Gontarz-Nowak K, Mazurek A, Nowak M, Wierzbicka-Rucińska K, Prystupa A. Sirtuins and Thyroid Gland. J Clin Med. 2021 Jul 20;10(14):3198. doi: 10.3390/jcm10143198. PMID: 34354226. Available from: pubmed.ncbi.nlm.nih.gov/34354226/
* He Y, Li B, Zhang X. NAD+ Metabolism in Endocrine Disorders: A Focus on Diabetes and Thyroid Disease. Int J Mol Sci. 2023 Aug 21;24(16):12999. doi: 10.3390/ijms241612999. PMID: 37622619. Available from: pubmed.ncbi.nlm.nih.gov/37622619/
* Zhang J, Wei D, Ma M, Wang H, Liu J. Impact of NAD+ on Thyroid Hormone Signaling. Front Endocrinol (Lausanne). 2021 Jun 28;12:699741. doi: 10.3389/fendo.2021.699741. eCollection 2021. PMID: 34293818. Available from: pubmed.ncbi.nlm.nih.gov/34293818/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.